Brii Biosciences Limited Stock
Stocks
2137
KYG1645A1094
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
04:08:33 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.9600 HKD | 0.00% |
|
-5.42% | -31.91% |
| Market Cap | 595M 693M 88.38M 76.16M 71.41M 65.18M 123M 8.45B 123M 847M 331M 4.26B 332M 325M 14.14B | P/E 2024 |
-1.32x | P/E 2025 | -4.11x |
|---|---|---|---|---|---|
| Enterprise Value | -1.34B -1.56B -199M -171M -160M -146M -276M -18.98B -277M -1.9B -743M -9.58B -745M -729M -31.76B | EV / Sales 2024 |
-32.4x | EV / Sales 2025 | -28.6x |
| Free-Float |
93.34% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Brii Biosciences Limited
| 1 week | -5.42% | ||
| Current month | +2.13% | ||
| 3 months | -16.52% | ||
| 6 months | -38.46% | ||
| Current year | -31.91% |
| 1 week | 0.94 |  | 1.06 |
| 1 month | 0.9 | | 1.14 |
| Current year | 0.9 | | 1.7 |
| 1 year | 0.9 | | 2.34 |
| 3 years | 0.8 | | 3.5 |
| 5 years | 0.8 | | 52.6 |
| 10 years | 0.8 | | 52.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Hong
CEO | Chief Executive Officer | 62 | 2018-02-22 |
An Kang Li
DFI | Director of Finance/CFO | 48 | 2020-08-31 |
Brian Johns
CTO | Chief Tech/Sci/R&D Officer | - | 2024-01-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhi Hong
CHM | Chairman | 62 | 2021-03-23 |
Martin Murphy
BRD | Director/Board Member | 83 | 2021-06-21 |
Hui Tang
BRD | Director/Board Member | 66 | 2021-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -5.42% | -48.39% | -67.24% | 88.38M | |
| -1.59% | -3.35% | +52.37% | +93.70% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +91.86% | 64.97B | |
| +0.30% | -0.69% | +52.56% | +10.23% | 26.51B | |
| -2.35% | -5.75% | -12.90% | +448.54% | 25.89B | |
| -8.37% | -12.43% | +2.08% | -16.71% | 25.64B | |
| -0.96% | +10.36% | +283.06% | +436.50% | 20.22B | |
| -0.51% | +0.23% | +35.77% | -18.70% | 19.98B | |
| -1.91% | -4.37% | +13.28% | +535.19% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +143.08% | 13.49B | |
| Average | -1.82% | -2.28% | +47.15% | +165.64% | 28.2B | |
| Weighted average by Cap. | -1.93% | -1.50% | +53.70% | +151.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 49.94M 58.19M 7.42M 6.4M 6M 5.47M 10.31M 709M 10.34M 71.14M 27.76M 358M 27.87M 27.26M 1.19B | 35.55M 41.42M 5.28M 4.55M 4.27M 3.9M 7.34M 505M 7.36M 50.64M 19.76M 255M 19.84M 19.41M 845M |
| Net income | -508M -592M -75.53M -65.08M -61.02M -55.7M -105M -7.22B -105M -724M -282M -3.64B -284M -277M -12.08B | -223M -259M -33.09M -28.51M -26.73M -24.4M -45.97M -3.16B -46.12M -317M -124M -1.6B -124M -122M -5.29B |
| Net Debt | -2.29B -2.67B -341M -294M -275M -251M -473M -32.56B -475M -3.27B -1.27B -16.44B -1.28B -1.25B -54.5B | -1.93B -2.25B -287M -247M -232M -212M -399M -27.42B -400M -2.75B -1.07B -13.84B -1.08B -1.05B -45.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | HK$0.9600 | 0.00% | 455,000 |
| 26-08-27 | HK$0.9600 | -6.80% | 3,237,500 |
| 26-08-26 | HK$1.030 | 0.00% | 377,000 |
| 26-08-25 | HK$1.030 | +1.98% | 373,000 |
| 26-08-24 | HK$1.010 | -0.49% | 1,688,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2137 Stock
Select your edition
All financial news and data tailored to specific country editions
